articleThe Lancet OncologyNov 9, 2011Closed access

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Tampere University · Tampere University · +28 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

700
total citations
FWCI
45.67
Percentile
100%
References
34
Citations per year

Authors

30

Topics & keywords

Keywords
  • Medicine
  • Cervical cancer
  • Vaccine efficacy
  • Cervical intraepithelial neoplasia
  • Serostatus
  • Clinical endpoint
  • Surrogate endpoint
  • Clinical trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding